Consonance Capital Management LP 13D and 13G filings for Ovid Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-17 3:13 pm Sale | 2020-12-31 | 13G | Ovid Therapeutics Inc. OVID | Consonance Capital Management LP | 0 0.000% | -6,058,505 (Position Closed) | Filing |
| 2021-02-16 2:22 pm Purchase | 2020-12-31 | 13G | Ovid Therapeutics Inc. OVID | Consonance Capital Management LP | 6,058,505 11.000% | 3,169,617 (+109.72%) | Filing |